These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28711372)

  • 1. Patient Reported Outcomes in Optimizing Myeloma Patients' Health-Related Quality of Life.
    King TA; King MT; White KJ
    Semin Oncol Nurs; 2017 Aug; 33(3):299-315. PubMed ID: 28711372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.
    Ramsenthaler C; Osborne TR; Gao W; Siegert RJ; Edmonds PM; Schey SA; Higginson IJ
    BMC Cancer; 2016 Jul; 16():427. PubMed ID: 27387201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for Selecting the Optimal Treatment in Newly Diagnosed Multiple Myeloma Patients.
    Steinbach M; Richards T; Faiman B
    Semin Oncol Nurs; 2017 Aug; 33(3):254-264. PubMed ID: 28683956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Young Adults with Multiple Myeloma.
    Devine H; Verina D
    Semin Oncol Nurs; 2017 Aug; 33(3):316-331. PubMed ID: 28712718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.
    Boland E; Eiser C; Ezaydi Y; Greenfield DM; Ahmedzai SH; Snowden JA
    J Pain Symptom Manage; 2013 Nov; 46(5):671-80. PubMed ID: 23535325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Experiences With Multiple Myeloma: A Meta-Aggregation of Qualitative Studies.
    Hauksdóttir B; Klinke ME; Gunnarsdóttir S; Björnsdóttir K
    Oncol Nurs Forum; 2017 Mar; 44(2):E64-E81. PubMed ID: 28222083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma.
    Sheridan CA
    Semin Oncol Nurs; 1996 Feb; 12(1):59-69. PubMed ID: 8650443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation.
    Sherman AC; Coleman EA; Griffith K; Simonton S; Hine RJ; Cromer J; Latif U; Farley H; Garcia R; Anaissie EJ
    Support Care Cancer; 2003 Sep; 11(9):568-74. PubMed ID: 12827482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should WOC nurses measure health-related quality of life in patients undergoing intestinal ostomy surgery?
    Pittman J; Kozell K; Gray M
    J Wound Ostomy Continence Nurs; 2009; 36(3):254-65. PubMed ID: 19448506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Rome SI; Jenkins BS; Lilleby KE;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():41-52. PubMed ID: 21816709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners.
    Molassiotis A; Wilson B; Blair S; Howe T; Cavet J
    Psychooncology; 2011 Jan; 20(1):88-97. PubMed ID: 20187072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with Multiple Myeloma: A Continuum-Based Approach to Cancer Survivorship.
    Kurtin S
    Semin Oncol Nurs; 2017 Aug; 33(3):348-361. PubMed ID: 28663078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine health maintenance in patients living with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Bilotti E; Gleason CL; McNeill A;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():25-40. PubMed ID: 21816708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychosocial experiences of women with breast cancer across the lifespan: a systematic review protocol.
    Campbell-Enns H; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):112-21. PubMed ID: 26447012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma.
    Noonan K; Colson K
    Semin Oncol Nurs; 2017 Aug; 33(3):279-291. PubMed ID: 28666621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.
    Van Der Wees PJ; Nijhuis-Van Der Sanden MW; Ayanian JZ; Black N; Westert GP; Schneider EC
    Milbank Q; 2014 Dec; 92(4):754-75. PubMed ID: 25492603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
    Kiely F; Cran A; Finnerty D; O'Brien T
    Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review.
    LeBlanc MR; Hirschey R; Leak Bryant A; LeBlanc TW; Smith SK
    Qual Life Res; 2020 Jun; 29(6):1419-1431. PubMed ID: 31848847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating the science of patient-reported outcomes assessment into clinical practice.
    Osoba D
    J Natl Cancer Inst Monogr; 2007; (37):5-11. PubMed ID: 17951224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-Based Guidelines for Preventing and Managing Side Effects of Multiple Myeloma.
    Bertolotti P; Pierre A; Rome S; Faiman B
    Semin Oncol Nurs; 2017 Aug; 33(3):332-347. PubMed ID: 28729122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.